Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

JAMA Neurology Author Interviews: Covering research, science, & clinical practice in the structure and function of the nervous system by American Medical Association

Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD. Related Content: Fremanezumab for the Trea...View more